Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acura Pharmaceuticals, Inc.    ACUR   US00509L7038

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Acura Pharmaceuticals, Inc. : Analysis Reports On Active Stocks: (NASDAQ: ACUR), (NYSE: SMFG)

04/25/2013 | 01:40pm US/Eastern
Recommend:
0

New York (April 25th, 2013) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) traded in the range of $2.56 and $2.74 during its latest trading session. The stock recorded the volume of 329,570 shares. Currently, it is at $2.68, up 3.67 from its previous close. Its average daily trading volume stands at 763,216 shares. Its MACD chart shows bullish trend. The company?s current market capitalization stands at $123.15 million.

Acura Pharmaceuticals stock has traded in the range of $1.06 and $4.50 in the past 52 weeks and has lost 17.13 percent of its value in the same time period. The stock has low volatility as its beta stands at 0.86.

Find out what could be next for ACUR here:

http://www.wallstreetscoop.net/market-scan/?symbol=ACUR


Sumitomo Mitsui Financial Group Inc. (NYSE: SMFG) stock is at $9.41, up 3.63 percent from its previous close of $9.08. The stock shows bullish trend as it made the up move with trading volume of 4.484 million shares, in contrast to the average daily trading volume of 2.044 million shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading in line with its 20 days SMA of $9.41.

Sumitomo Mitsui Financial stock is mildly volatile with its beta at 1.03. The company?s market capitalization is at $63.70 billion.

Find out more on SMFG here:

http://www.wallstreetscoop.net/market-scan/?symbol=SMFG

About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:
Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009


© Accesswire 2013
Recommend :
0
React to this article
Latest news on ACURA PHARMACEUTICALS, INC
1d ago PFIZER : Acura Pharmaceuticals Reports Return of Product Rights
04/10DJACURA PHARMACEUTICALS : Ends Licensing Pact With Pfizer
04/10 ACURA PHARMACEUTICALS : Announces Return of Product Rights
03/10 ACURA PHARMACEUTICALS, INC : Regulation FD Disclosure, Financial Statements and ..
03/05 Acura Pharmaceuticals to Present at the 26th Annual ROTH Conference
03/03 ACURA PHARMACEUTICALS, INC. : Acura Pharmaceuticals Announces Fourth Quarter and..
02/18 Acura Pharmaceuticals to Host 2013 Financial Results Conference Call on March..
01/31 ACURA PHARMACEUTICALS, INC. : Acura Pharmaceuticals Assigned Patent
2013 ACURA PHARMACEUTICALS, INC. : ACURA PHARMACEUTICALS, INC FILES (8-K) Disclosing ..
2013 ACURA PHARMACEUTICALS, INC. : Acura Pharmaceuticals Secures $10.0M of Debt Finan..
Advertisement
Chart
Duration : Period :
Acura Pharmaceuticals, Inc Technical Analysis Chart | ACUR | US00509L7038 | 4-Traders
Income Statement Evolution
Acura Pharmaceuticals, Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF